共 154 条
[1]
Villanueva A(2019)Hepatocellular Carcinoma N Engl J Med 380 1450-1462
[2]
Bruix J(2017)Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial Lancet 389 56-66
[3]
Qin S(2017)Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial Lancet 389 2492-2502
[4]
Merle P(2013)Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancy World J Gastroenterol 19 5430-5438
[5]
Granito A(2016)Preliminary Outcome of Microwave Ablation of Hepatocellular Carcinoma: Breaking the 3-cm Barrier? J Vasc Interv Radiol 27 623-630
[6]
Huang YH(2015)Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes World J Gastroenterol 21 1554-1566
[7]
Bodoky G(2014)Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes Radiology 270 888-899
[8]
Pracht M(2017)Outcomes of microwave ablation for hepatocellular carcinoma adjacent to large vessels: a propensity score analysis Oncotarget 8 28758-28768
[9]
El-Khoueiry AB(2018)Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure European Radiology 29 2706-2715
[10]
Sangro B(2005)Management of hepatocellular carcinoma Hepatology 42 1208-1236